This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Prognosis

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

  • in 45% of patients there is symptomatic resolution within 20 days
  • in 25% of patients symptoms may persist for two months
  • study evidence revealed that psychiatric and neurological disorders persisted for more than two months in 30% of patients - however a causal link with mefloquine prophylaxis was not firmly established

Reference:

  • Prescribers' Journal (1999), 39 (3), 154-63.
  • Schlagenhauf P et al. The position of mefloquine as a 21st century malaria chemoprophylaxis.Malar J. 2010 Dec 9;9:357.

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.